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Abstract
The pro-apoptotic function of p53 has been well defined in preventing genomic instability and cell transformation.
However, the intriguing fact that p53 contributes to a pro-survival advantage of tumor cells under DNA damage conditions
raises a critical question in radiation therapy for the 50% human cancers with intact p53 function. Herein, we reveal an anti-
apoptotic role of mitochondrial p53 regulated by the cell cycle complex cyclin B1/Cdk1 in irradiated human colon cancer
HCT116 cells with p53
+/+ status. Steady-state levels of p53 and cyclin B1/Cdk1 were identified in the mitochondria of many
human and mouse cells, and their mitochondrial influx was significantly enhanced by radiation. The mitochondrial kinase
activity of cyclin B1/Cdk1 was found to specifically phosphorylate p53 at Ser-315 residue, leading to enhanced
mitochondrial ATP production and reduced mitochondrial apoptosis. The improved mitochondrial function can be blocked
by transfection of mutant p53 Ser-315-Ala, or by siRNA knockdown of cyclin B1 and Cdk1 genes. Enforced translocation of
cyclin B1 and Cdk1 into mitochondria with a mitochondrial-targeting-peptide increased levels of Ser-315 phosphorylation
on mitochondrial p53, improved ATP production and decreased apoptosis by sequestering p53 from binding to Bcl-2 and
Bcl-xL. Furthermore, reconstitution of wild-type p53 in p53-deficient HCT116 p53
2/2 cells resulted in an increased
mitochondrial ATP production and suppression of apoptosis. Such phenomena were absent in the p53-deficient HCT116
p53
2/2 cells reconstituted with the mutant p53. These results demonstrate a unique anti-apoptotic function of
mitochondrial p53 regulated by cyclin B1/Cdk1-mediated Ser-315 phosphorylation in p53-wild-type tumor cells, which may
provide insights for improving the efficacy of anti-cancer therapy, especially for tumors that retain p53.
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Introduction
In mammalian cells, tumor suppressor p53 plays important roles
in a diversity of physiologic functions. Cellular p53 functions as a
tumor suppressor by increasing genomic stability and inhibiting
cell transformation [1], initiating apoptosis upon defected DNA
damage repair [2,3]. During stress, p53 rapidly translocates to the
outer-membrane of mitochondria and engages with Bcl-2 family
proteins, leading to permeabilization of the mitochondrial outer-
membrane, followed by the release of cytochrome c and initiation
of apoptosis [4,5,6]. p53-regulated pro-apoptotic function is
believed to contribute to the efficacy of anti-cancer therapy [7].
p53 may also possess cell survival activity, as suggested by the
radioadaptive resistance of p53-positive cells treated with frac-
tionated irradiation [8], and the observation that lost-of–function
p53 has been linked with increased cell sensitivity to radiation and
enhanced apoptosis [9,10]. Mitochondrial localization of p53 can
exert an anti-apoptotic function [11,12]. In addition, p53
reportedly acts as a pro-survival factor by promoting mitochon-
drial biogenesis [13], mitochondrial DNA repair and synthesis
[14,15,16], and respiration [17]. The molecular mechanism
underlying such p53-mediated anti-apoptotic response in the
context of genotoxic stress remains to be elucidated.
One cause of p53 activation by radiation is due to its
phosphorylation by the cell cycle regulator cyclin B1 and its
kinase partner Cdk1 [18]. The cyclin B1/Cdk1 complex (so-called
Mitosis Promoting Factor, MPF) controls the mitotic entrance
from G2 to M phase [19,20]. As a checkpoint, the cyclin B1/Cdk1
complex also arrests cell cycle at the G2/M phase allowing cells
sufficient time to repair damaged DNA and influencing various
pro-survival signaling pathways before entering mitosis [21,22].
Elevated levels of cyclin B1/Cdk1 activity account for the chemo/
radio-resistance in post-treatment to head and neck cancers
[23,24]. Aberrant activity of cyclin B1/Cdk1 is found in the
radiation-derived tumor resistance [25], and inhibition of cyclin
B1/Cdk1 activity enhances tumor radiosensitivity by increasing
apoptosis [26,27]. The cyclin B1/Cdk1 complex is able to interact
with both pro- and anti-apoptotic proteins including BAD, Bcl-2,
Bcl-xL, Mcl-1, caspase-9 and survivin [28,29,30,31,32]. However,
the exact mechanisms of cyclin B1/Cdk1-mediated mitochondrial
functions and their potential correlations with p53 are still
unknown.
p53, as a pivotal factor in both gene expression [33] and cell
cycle regulation [34,35], can be potentially phosphorylated at least
on 17 amino-acid sites by various kinases accounting for its
diversified roles. In particular, the Ser-315 residue on p53 is
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examined cyclin B1/Cdk1-mediated p53 Ser-315 phosphorylation
occurred in mitochondria and its relevance to the radioresistant
phenotype of p53 wild-type tumor cells. Our data demonstrate a
novel pro-survival signaling network initiated by radiation-induced
mitochondrial targeting of cyclin B1, Cdk1 and p53, and
subsequent mitochondrial p53 Ser-315 phosphorylation causing
enhanced mitochondrial ATP generation and mitochondrial
membrane potential. These results suggest that DNA damaging
anti-cancer reagents can activate an adaptive response via nuclear-
to-mitochondrial protein trafficking to protect mitochondrial
integrity and suppress apoptosis.
Results
Enrichment of mitochondrial p53, cyclin B1 and Cdk1 by
irradiation
Activation of p53 and cell cycle regulators has been well
demonstrated in radiation-induced DNA damage response [37].
Induction of p53, cyclin B1 and Cdk1 was confirmed in irradiated
human colon cancer cell with wild-type p53 (HCT116 p53
+/+)
compared with the p53 deficient (HCT116 p53
2/2) cells. The
steady-state levels of p53, cyclin B1 and Cdk1 were increased in
HCT116 p53
+/+ (Figure 1A, left panel) and the induction of cyclin
B1 and Cdk1 was also observed in the HCT116 p53
2/2 cells
following exposure to radiation (Figure 1A, right panel), indicating
that radiation-induced cyclin B1/Cdk1 expression was indepen-
dent of p53 status. Concomitantly, a basal level of p53, cyclin B1
and Cdk1 was confirmed in the mitochondria of HCT116 p53
+/+
cells and a substantial amount of all three proteins was detected in
the mitochondria of HCT116 p53
+/+ cells after irradiation
(Figure 1B). Compared to their cytosolic distribution, a relatively
higher concentration of p53, cyclin B1 and Cdk1 was detected in
mitochondria and the mitochondrial influx of all three proteins
were significantly enhanced in HCT116 p53
+/+ cells by irradiation
(Figure 1C). In the p53 deficient HCT116 p53
2/2 cells, a basal
mitochondrial cyclin B1/Cdk1 was also present in the mitochon-
dria and was enhanced by irradiation, indicating that mitochon-
drial influx of p53 and cyclin B1/Cdk1 was mutually independent.
The mitochondrial enrichment of cyclin B1 and Cdk1 was also
evidenced in other cell lines with both wild-type and mutant p53
such as MCF-10A, MDA-MB-231 and JB6, and p53 deficient
HK-18 cells (Figure 1D). These data indicate that cyclin B1 and
Cdk1 are present in the mitochondria of mammalian cells and
their mitochondrial influx is significantly enhanced by DNA
damage stress.
Active mitochondrial Cdk1 interacted and
phosphorylated p53 at Ser-315
To determine whether mitochondrial cyclin B1/Cdk1 complex
is capable to phosphorylate p53 in mitochondria, mitochondrial
fractionation were performed from irradiated HCT116 p53
+/+
cells and interaction between mitochondrial Cdk1 and p53 was
detected by co-immunoprecipitation. Robust Cdk1/p53 interac-
tion was detected in the mitochondrial fraction of irradiated HCT
116 p53
+/+ cells (Figure 2A); this increased Cdk1/p53 interaction
started as early as 2 to 4 hours after irradiation (Figure S1A). To
verify whether mitochondria-translocated Cdk1 is active, in vivo
kinase assay was performed using immune-isolated Cdk1 from
mitochondrial fraction of irradiated HCT 116 p53
+/+ cells with
GST-tagged synthesized p53 (wild-type, Ser-315 to Ala or Ser-315
to Asp mutants) and Histone protein (H1) as the target substrates.
Results in Figure 2B demonstrated that mitochondrial Cdk1
indeed demonstrated its kinase activity and phosphorylated wild-
type p53 and the positive control Histone H1; in contrast, Cdk1
mediated phosphorylation was markedly reduced in the mutant
p53 (S315A, phosphorylation inhibit) but not the phosphorylation
counterfeit mutant p53 (S315D) [38]. The substrate specificity of
the kinase assay was confirmed in Figure S1B. Together, these
results demonstrate that mitochondrial translocated Cdk1 retains
its kinase activity and is able to phosphorylate p53 at Ser-315.
Mitochondrial p53 Ser-315 was specifically
phosphorylated by mitochondrial cyclin B1/Cdk1 after
irradiation
p53 Ser-315 phosphorylation has been shown to be induced by
irradiation [39] and confirmed by our present study (Figure S2A).
To address the question of whether the stress-induced p53 protein
is, at least in part, translocated to mitochondria and its Ser-315
residue is targeted by cyclin B1/Cdk1 complex, we measured the
levels of phosphorylated p53 in mitochondrial fractions isolated
from HCT116 p53
+/+ at different time intervals after irradiation.
Although a high steady-level of radiation-induced total mitochon-
drial p53 was maintained throughout 24 hours after irradiation,
phosphorylated p53 Ser-315 was markedly increased during the
hours (Figure 3A), suggesting that the phosphorylation may
happen within mitochondria after irradiation. The phosphoryla-
tion of mitochondrial p53 was further confirmed in irradiated
mouse xenograft tissue as shown in Figure S2B. In agreement,
inhibition of cyclin B1 or Cdk1 by short-interference siRNA
knockdown drastically diminished the Ser-315 phosphorylation of
mitochondrial p53 of irradiated HCT116 p53
+/+ cells without
altering the total mitochondrial p53 level (Figure 3B). Although
the expression of cyclin B1 and Cdk1 was partially reduced in the
whole cell lysate (Figure S2C), it is noteworthy that mitochondrial
cyclin B1 and Cdk1 levels were markedly reduced by the specific
siRNAs, suggesting that mitochondrial translocation of cyclin B1
and Cdk1 is sensitive to the overall cyclin B1 and Cdk1 cellular
protein expression. In addition, siRNA knockdown of cyclin B1
did not affect mitochondrial translocation of Cdk1, and vice versa,
indicating the independent mitochondrial influx of cyclin B1 and
Cdk1 (Figure 3B).
To further understand the mitochondrial trafficking of cyclin B1
and Cdk1, we constructed vectors with mitochondria targeting
sequence (MTS) derived from human cytochrome c oxidase
subunit 8a (Cox8a) [40,41] and inserted at the N-terminal of cyclin
B1, Cdk1 and delCdk1 (truncated Cdk1 with deletion at its
catalytic loop, residue 122–132, delCdk1) [42] as shown in
Figure 3C. The specificity of MTS-mediated mitochondrial
localization of cyclin B1 and Cdk1 was validated by western blot
and fluorescence microscopy with Mitotracker (Figure 3D and
Figures S2D and E). The mitochondrial p53 Ser-315 phosphor-
ylation was significantly enhanced in cells co-transfected with
MTS-cyclin B1 and MTS-Cdk1 (Figure 3E). In contrast, the
mitochondrial p53 Ser-315 phosphorylation was partially com-
promised by co-transfecting MTS-cyclin B1 with MTS-delCdk1
that lacks the Cdk1 catalytic loop (Asp-128 and Lys-130 motif) for
binding to c-phosphate ATP required for the Cdk1-mediated
phosphorylation [43]. Together, these results strongly suggest that
mitochondrial p53 Ser-315 is specifically phosphorylated by
mitochondrial cyclin B1/Cdk1 that was enhanced by the stress
of ionizing radiation.
p53 Ser-315 phosphorylation was involved in
mitochondrial ATP production
To examine the function of the mitochondrial p53 phosphor-
ylated by cyclin B1/Cdk1, we measured the mitochondrial ATP
p53 Anti-Apoptotic Function
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Although ATP production was considerably higher in p53
+/+
cells than p53 deficient cells, restoring p53 into HCT116 p53
2/2
cells completely rescued the ATP production. However, wild-type
or S315D mutant p53 appeared to have higher ATP production in
comparison with p53 deficient or mutant p53 S315A expressing
cells (Figure 4A). The expression levels of p53 in HCT116 cells
with p53
+/+, p53
2/2, p53WT, p53-S315A and p53-S315D
mutants were confirmed by western blots (Figure S3A). The
presence of p53 is critical for mitochondrial generation of ATP, as
it transcriptionally regulates a group of mitochondrial respiration
genes [17,44,45] and plays a direct role in mitochondrial ATP
machinery [46]. Moreover, we also observed that mitochondrial
ATP production was induced by the radiation stimulus, possibly
due to the mitochondrial influx of proteins (Figure S3B).
We further examined the importance of Ser-315 p53 phos-
phorylation by cyclin B1/Cdk1 by inhibiting cyclin B1 and Cdk1
with siRNA. Results indicated that the siRNAs against cyclin B1
or Cdk1 were effective in reducing mitochondrial ATP production
in HCT116 p53
+/+ and HCT116 p53
2/2 cells expressing wild-
type p53, approximately 30%; while blocking cyclin B1 or Cdk1 in
the p53 deficient or mutant p53 S315A transfectants resulted in
merely 5 and 15% reduction in ATP production, respectively
(Figure 4B). Therefore, we rationalized that p53 and its Ser-315
phosphorylation is essential for mitochondrial ATP production.
Consistent with these results, ATP production was strikingly
increased in HCT116 p53
+/+ and the wide-type p53 transfectants
of HCT116 p53
2/2 that were additionally transfected with
mitochondria-targeted cyclin B1/Cdk1 while little ATP enhance-
ment was detected in the p53 deficient or mutant p53 transfectants
(Figure 4C). The p53-related mitochondrial ATP production
appeared unrelated to the status of mitochondrial biogenesis since
no difference in expression of mitochondrial fusion and fission
proteins, GTPase, Mfn1 and Drp1, was observed (Figure S4).
Thus, we conclude that the enhanced mitochondrial ATP
production was due to the p53 Ser-315 phosphorylation by
mitochondrial cyclin B1/Cdk1.
Cyclin B1/Cdk1-mediated mitochondrial p53 Ser-315
phosphorylation maintained mitochondrial membrane
potential and cell viability
Next, we addressed the question of whether mitochondrial
membrane potential (Dym) and cell viability are influenced by the
status of cyclin B1/Cdk1-mediated mitochondrial p53 phosphory-
lation. Compared to the basal Dym, cells with wild-type p53
(HCT116 p53
+/+ or HCT116 p53
2/2 rescued with p53 wild-type)
retained a higher Dym than HCT116 p53
2/2 cells and the
HCT116 p53
2/2 cells expressing mutant p53 after irradiation
(Figure 5A). Consistent with these results, cells with wild-type p53
also appeared higher cell viability as measured by MTT reduction
thanthe cellswith deficientp53 or mutantp53 aftertreated byeither
sham or 5 Gy radiation (Figure 5B). Moreover, Cells with wild type
p53 status have significantly higher survival determined by
clonogenic survival assay after 5 Gy irradiation, whereas cells with
p53deficientorAlaninemutatedSer-315onlyhad40%survivalrate
compared to p53 wild type expressing cells (Figure S5A). These
resultssuggestthat p53 maynot onlybeabletoprotectmitochondria
but also provide long term survival for cells against radiation insult.
Figure 1. Mitochondrial localization of p53, cyclin B1 and Cdk1 was enhanced by irradiation. Human colon cancer HCT116 cells with
wild-type p53
+/+ (left panel) or p53
2/2 deficient (right panel) were treated by 5 Gy radiation. (A) Induction of p53, cyclin B1 and Cdk1 in whole cell
lysate were determined by immunoblotting. (B) Mitochondrial p53, cyclin B1 and Cdk1 were measured by immunoblotting with 20 mg total protein
of mitochondrial fraction purified from control and irradiated HCT116 p53
+/+ cells (Cox4 as mitochondrial fraction marker). (C) Mitochondrial (Mito)
and cytosolic (Cyto) p53, cyclin B1 and Cdk1 were detected by immunoblotting with 20 mg total protein of each fraction purified from irradiated
HCT116 p53
+/+ and p53
2/2 cells (Cox4 and a-tubulin served as mitochondrial and cytosolic markers respectively). (D) Mitochondrial p53, cyclin B1
and Cdk1 were detected by immunoblotting with 20 mg total protein of mitochondrial fraction purified from irradiated and control human breast
epithelial cell MCF-10A, breast cancer cell MDA-MB-231, immortalized normal mouse skin epithelial JB6 cells and immortalized human skin
keratinocytes (HK18) with deficient p53.
doi:10.1371/journal.pone.0012341.g001
Figure 2. Mitochondrial Cdk1 interacted and phosphorylated
p53. (A) Mitochondria fractions (100 mg) from control (sham-irradiated)
and irradiated HCT116 p53
+/+ cells (HCT116 p53
2/2 cells included as a
negative control) were immunoprecipitated (IP) with p53 antibody
followed by immunoblotting (IB) with Cdk1 antibody (top panel); IP
with Cdk1 antibody followed by IB with p53 antibody (bottom panel).
(B) Kinase assay was performed with Cdk1 purified with IP from total
2.4 mg of mitochondrial fraction isolated from irradiated HCT116 p53
+/+
and incubated with 8 mg of GST-p53 (wild-type or mutants at S315A or
S315D). The same amount of histone H1 was included as a positive
phosphorylation substrate for Cdk1, and GST-protein only served as a
negative control (mitochondrial Cdk1 mediated p53 phosphorylation
was estimated by densitometry in comparison to the phosphorylation
level of histone H1).
doi:10.1371/journal.pone.0012341.g002
p53 Anti-Apoptotic Function
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against cyclin B1 or Cdk1 before irradiation significantly reduced
mitochondrial membrane potential and cell viability in cells with
wild-type p53, but had minimal effects on cells with deficient or
mutated p53 (Figures 5C and D). Further studies with co-transfection
of mitochondria-targeted cyclin B1/Cdk1 revealed that radiation-
induced reduction of Dym and cell viability was nominal in p53 wild-
type expressing cells. In contrast, the overexpression of MTS-cyclin
B1/Cdk1 had slight effects on both mitochondrial membrane
potential and cell viability in cells containing deficient or mutated
p53 post-irradiation (Figures 5E and F). These results demonstrate
that Ser-315 phosphorylation on p53 by cyclin B1/Cdk1 in
mitochondria is essential for maintaining mitochondrial membrane
potential and cell viability under the stress of ionizing radiation.
Figure 3. Radiation stimulated cyclin B1/Cdk1-mediated mitochondrial p53 Ser-315 phosphorylation. (A) p53 Ser-315 phosphorylation
was detected by immunoblotting with anti-phospho-p53(S315) antibody with 20 mg mitochondrial fractions from irradiated HCT116 p53
+/+.( B) Total
protein and phosphorylated p53, cyclin B1, and Cdk1 were determined in irradiated HCT116 p53
+/+ transfected with siRNAs against cyclin B1, Cdk1 or
scrambled seq. (C) Structural illustration of fusion protein containing mitochondria-targeted-sequence (MTS) linked with cyclin B1-EGFP, Cdk1-RFP, as
well as a mutant form delCdk1 with the deletion of catalytic domain of Cdk1 (aa 122–132). (D) Fluorescence images of HCT116 p53
+/+ cells
transfected with mitochondria-targeted cyclin B1-EGFP and Cdk1-RFP with Mitotracker mitochondria staining (scale bar=5 mm). (E) Ser-315
phosphorylation of mitochondrial p53 was determined in HCT116 p53
+/+ cells co-transfected with empty vectors MTS-EGFP/MTS-RFP, or with MTS-
cyclin B1 fused with EGFP (MTS-cyclin B1) and MTS-Cdk1 fused with RFP (MTS-Cdk1), or with MTS-cyclin B1 fused with EGFP and MTS-delCdk1 fused
with RFP (delCdk1). In addition, HCT116 p53
+/+ cells without transfection was included as a control.
doi:10.1371/journal.pone.0012341.g003
p53 Anti-Apoptotic Function
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mitochondria-mediated apoptosis
To determine the potential effect of cyclin B1/Cdk1-
phosphorylated p53 in mitochondria-mediated apoptosis, we
measured the apoptosis in irradiated HCT116 p53
+/+ and
HCT116 p53
2/2 cells with different p53 status. Little
differences of the radiation-induced apoptosis were detected
among HCT116 cells regardless of their p53 status (Figure
S5B), which agreed with the previous report [47]. However,
inhibition of cyclin B1 by siRNA knockdown along with
irradiation dramatically increased the ratio of apoptotic
population in cells with wild-type p53, but not in the cells with
mutant p53 (Figure S5C). These results suggest that mitochon-
drial cyclin B1/Cdk1 is required for anti-apoptotic response
Figure 4. Cyclin B1/Cdk1-mediated p53 phosphorylation regulated mitochondrial ATP production. (A) Mitochondrial ATP production
was measured in exponentially growing HCT116 p53
+/+, HCT116 p53
2/2, or stable HCT116 p53
2/2 transfectants with p53 wild-type, or S315A/S315D
mutants (n=3; mean 6 SEM; **P,0.01). (B) Mitochondrial ATP production was measured in the same set of cells additionally transfected with cyclin
B1, Cdk1 or scrambled siRNAs for 24 h (n=3; mean 6 SEM; *P,0.05; **P,0.01). (C) Mitochondrial ATP production was measured in the same set of
cells transfected with MTS-EGFP and MTS-RFP, or MTS-cyclin B1 and MTS-Cdk1, or MTS-cyclin B1 and MTS-delCdk1 (n=3; mean 6 SEM; **P,0.01).
doi:10.1371/journal.pone.0012341.g004
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B1/Cdk1 also significantly decreased the apoptotic ratio by
approximately 20% in cells expressing wild-type p53 after
exposure to radiation (Figure 6A). Since initiation of mito-
chondria-mediated apoptosis starts with permeabilization of the
mitochondrial outer membrane and the release of mitochon-
drial cytochrome c that triggers subsequent activation of
caspase cascades [48], we measured levels of cytosolic and
mitochondrial cytochrome c and observed a strikingly less
cytosolic cytochrome c released from mitochondria after
irradiation in cells expressing wild-type p53 transfected with
MTS-cyclin B1/MTS-Cdk1, but not in cells with deficient or
mutant p53 (Figure 6B).
In mitochondria-mediated pathways, p53 is reported to play an
apoptotic role through disrupting the function of mitochondrial-
membrane associated Bcl-2 and Bcl-xL [49,50]. We then tested
whether the cyclinB1/Cdk1-phosphorylated p53 interrupts its
association with Bcl-2 or Bcl-xL. Results shown in Figure 6C
indicated that levels of Bcl-2 or Bcl-xL protein pulled down by
anti-p53 were reduced in irradiated cells transfected with MTS-
cyclin B1/Cdk1, which was noticeably increased by transfection
with siRNAs against cyclin B1 or Cdk1 (Figure 6C). These
findings suggest a new important link between cyclin B1/Cdk1-
mediated p53 phosphorylation and mitochondrial apoptosis, in
which the phosphorylation was able to lead to reduced
association between p53/Bcl-2 and p53/Bcl-xL, followed by
inhibition of mitochondria-mediated apoptosis. Overall, we
conclude that the mitochondrial cyclin B1/Cdk1-induced p53
phosphorylation functions as an anti-apoptotic event via increas-
ing mitochondrial ATP production, maintaining mitochondrial
membrane potential, and interrupting the p53/Bcl-2 and p53/
Bcl-xL association.
Figure 5. Cyclin B1/Cdk1-mediated p53 phosphorylation enhanced mitochondrial membrane potential and cell viability.
Mitochondrial membrane potential (A) and cell viability (B) were measured in irradiated HCT116 p53
+/+, p53
2/2, or HCT116 p53
2/2 cells stably
transfected with wild-type p53, or S315A/S315D mutants (n=3; mean 6 SEM; **P,0.01). Mitochondrial membrane potential (C) and cell viability (D)
were measured in the same set of cells additionally transfected with cyclin B1 or Cdk1 siRNAs for 24 h (n=3; mean 6 SEM; *P,0.05; **P,0.01).
Mitochondrial membrane potential (E) and cell viability (F) were measured in the same set of cells additionally co-transfected with MTS-EGFP and
MTS-RFP, or MTS-cyclin B1 and MTS-Cdk1, or MTS-cyclin B1 and MTS-delCdk1 (n=3; mean 6 SEM; *P,0.05; **P,0.01).
doi:10.1371/journal.pone.0012341.g005
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PLoS ONE | www.plosone.org 7 August 2010 | Volume 5 | Issue 8 | e12341Figure 6. Cyclin B1/Cdk1-mediated p53 phosphorylation inhibited mitochondria-mediated apoptosis. (A) HCT116 p53
+/+, HCT116
p53
2/2 and HCT116 p53
2/2 transfectants of wild-type, or mutant S315A, S315D p53 were co-transfected with MTS-EGFP and MTS-RFP, MTS-cyclin B1
and MTS-Cdk1, or MTS-cyclin B1 and MTS-delCdk1 for 24 h and irradiated with 5 Gy. Apoptotic cells with sub G0/G1 DNA content were measured
24 h post-irradiation by flow cytometry (n=3; mean 6 SEM; **P,0.01). (B) Cytosolic and mitochondrial cytochrome c in the same set of cells was
measured 24 h after 5 Gy irradiation (a-tubulin and Cox4 included as loading controls). (C) Cyclin B1/Cdk1-mediated p53 phosphorylation inhibited
the interaction of p53 to Bcl2 or Bcl-xL p53. HCT116 p53
+/+ cells transfected with MTS-cyclin B1/MTS-Cdk1 or siRNAs against cyclin B1/Cdk1 for 24 h
p53 Anti-Apoptotic Function
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Under different stress conditions, the tumor suppressor p53 is
shown to translocate to mitochondria [4,51] to induce pro- or anti-
apoptotic responses depending on its phosphorylation status
[8,10,15,52]. Although the pathways accounting for p53 regulated
pro-apoptotic functions are well defined [53], the anti-apoptotic
response induced by mitochondrial p53 is largely unknown. In this
report, using p53 wild type and deficient tumor cells, we provide
the circumstantial evidence suggesting a novel pro-survival
regulation of mitochondrial p53 Ser-315 phosphorylation by
cyclin B1/Cdk1 that are also translocated to mitochondria. In
response to ionizing radiation, not only the total protein levels of
p53 and cyclin B1/Cdk1 are enhanced but also a substantial
amount of each protein is increased in mitochondria. The
mitochondrial cyclin B1/Cdk1 is found to phosphorylate p53 at
Ser-315 residues, causing an increased mitochondrial integrity
with enhanced ATP production and mitochondrial membrane
potential and reduced apoptosis.
Approximately 50 percent of human cancers contain different
p53 mutations [54,55,56]. It has been faithfully believed that the
major function of p53 is to induce apoptosis and the defects in p53
apoptotic function lead to the possibility of cell transformation and
tumor-growth advantages [57,58]. However, recent reports
suggest that p53 may provide protective functions for endothelial
cell of gastrointestinal track against radiation [10]. Additional
evidences indicate that p53 mutations in two human sarcoma cell
lines are linked with their radiosensitivity [59], and the presence of
p53 in mitochondria appears not to be associated with
mitochondrial apoptosis [11,47]. Our evidence present that
mitochondrial p53 acts as an advocate of mitochondrial integrity
with anti-apoptotic function suggesting a complex regulation on
mitochondrial p53 and apoptosis. The mechanism of such pro-
survival function of mitochondrial p53 is linked with the kinase
activity of cyclin B1/Cdk1 that also translocate to mitochondria
upon genotoxic stress. Inhibition of cyclin B1/Cdk1 by siRNA
resulted in reduction of cell viability, mitochondrial membrane
potential that led to increased apoptotic cell numbers. Co-
overexpression of the intact mitochondrial cyclin B1/Cdk1
resulted in the opposite phenotypes. In contrast, the presence or
absence of cyclin B1/Cdk1 in mitochondria showed little effect in
radiosensitivity of cells expressing deficient p53 or Ser-315
mutated p53. In the light of the recent study reporting that
inhibition of Cdk1 leads to p53-mediated apoptosis [60], our data
extend the current knowledge with mechanistic insights that
phosphorylation of mitochondrial p53 by cyclin B1/Cdk1
preserves mitochondrial integrity and suppresses mitochondria-
mediated apoptosis.
The cyclin B1/Cdk1-mediated Ser-315 phosphorylation is found
to sequester p53 from binding to anti-apoptotic Bcl-2 and Bcl-xL,
which arethemajoranti-apoptotic proteinslocated inmitochondria
[61,62]. Based on these findings, it is clear that p53 Ser-315 is
phosphorylated by mitochondrial cyclin B1/Cdk1 complex after it
enters mitochondria. However, our current data cannot exclude the
possibility that the phosphorylated p53 by cyclin B1/Cdk1 in
mitochondria may be able to migrate to cytoplasm and inhibit the
extrinsic pathways towards apoptosis. We, therefore, conclude that
the improvement of overall mitochondrial integrity and ATP
production correlated with the inhibited mitochondrial extrinsic
apoptosis may contribute to a significant portion of resistance to
genotoxic stress. With these results in mind together with the
proposed pro-survival functions of p53 [63], we propose that the
specific localization and phosphorylation status of p53 in mito-
chondria should be considered as a major factor in deciding anti-
apoptotic response.
This study has presented evidences showing irradiation, at the
moderate dose of 5 Gy, induced mitochondrial influx of p53, cyclin
B1 and Cdk1, but does not include the question of which
mechanisms causing the translocation of these nuclear proteins to
mitochondria. There is a possibility that elevated levels of cellular
and mitochondrial ROS or mitochondrial DNA damage induced
by radiation is responsible for such protein translocation. However,
nuclear DNA damage, a prominent feature of irradiation stress in
mammalian cells, could serve as the key factor triggering such
subcellular protein traffic. Therefore, our study strongly suggests
that the mitochondrial protein influx after genotoxic radiation is
initiatedby thenuclearDNAdamage. Further studies areneededto
elucidate the detailed mechanisms accounting for the translocation
of proteins from nucleus to mitochondria.
Multiple kinases and phosphatases in mammals are identified to
translocate to mitochondria and play critical roles in modulating
mitochondrial function [64]. We show herethat irradiation not only
stimulated the expression of cyclin B1 and Cdk1, but also promoted
their translocation to mitochondria where the p53 Ser-315 is
phosphorylated by Cdk1 that apparently formed the active complex
with its partner cyclin B1 in the mitochondria. Although p53
phosphorylation by cyclin B1/Cdk1 has been previously described
[36] and p53 phosphorylation does not induce its mitochondrial
translocation under stress [65], our current study suggests a novel
feature of cyclin B1/Cdk1 that phosphorylates p53 within
mitochondria. In this case, accumulation of nuclear DNA damage
induced by irradiation reaching a certain threshold is able to trigger
adaptive cellular response by activating a nuclear-to-mitochondrial
protein influx including p53, cyclin B1 and Cdk1. Such mitochon-
dria-targeted protein influx under a critical DNA damage condition
appears to quickly enhance mitochondrial functions in order to
supply sufficient cellular energy demand required for DNA damage
repair. However, in p53 deficient or Ser 315-mutated p53
expressing cells, such radioadaptive response is absent possibly
due to the lack of cyclin B1/Cdk1-mediated mitochondrial p53
phosphorylation and a consequential improvement of mitochon-
drial function. Our data also suggest that restoration of wild-type
p53 along with mitochondria-targeted cyclin B1/Cdk1 reinstated
their mitochondrial function. Further characterization of mito-
chondrial function in p53 mutant versus p53 wild type tumor cells
under geno- and cytotoxic conditions will generate important
insights to explain the different response of cancer patients
undergoing anti-cancer therapy. Combined this novel report with
previously published results, we propose a mitochondria-mediated
adaptive radioprotection of tumor cells with intact p53 status. As
illustrated inFigure7,mitochondrial translocation ofp53and cyclin
B1/Cdk1 is activated under acute DNA damage response. The
phosphorylation of mitochondrial p53 by cyclin B1/Cdk1 stabilizes
mitochondrial membrane potential and enhances mitochondrial
ATP production, sequentially supplies the ATP required to repair
damaged DNA and other critical cellular elements. Our model of
mitochondrial p53 phosphorylation by cyclin B1/Cdk1 signaling
cascade provides an important approach to further elucidate the
mechanism underlying therapy-resistant phenotype of tumor cells
against genotoxic stress.
followed by 5 Gy irradiation. Cell lysates were immunoprecipitated with p53 antibody (IP) followed by immunoblotted (IB) using Bcl-2, Bcl-xL or p53
antibodies. HCT116 p53
2/2 cell lysates were included as negative control.
doi:10.1371/journal.pone.0012341.g006
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can induce the gene expression of p53 and cyclin B1/Cdk1 but
also enhance their translocation to mitochondria. The subsequent
phosphorylation of p53 Ser-315 by mitochondria-translocated
cyclin B1/Cdk1 appears to be an important step in enhancing
mitochondrial integrity with increased mitochondrial ATP pro-
duction and reduced mitochondrial apoptosis for tumor radiore-
sistance. Targeting such nuclear-to-mitochondrial protein traffic
may have a profound implication in improving the efficacy of
tumor radiotherapy.
Materials and Methods
Cell culture and radiation exposure
Human colon carcinoma cell lines HCT116 p53
+/+ and
HCT116 p53
2/2 were kindly provided by Dr. Bert Vogelstein
(Johns Hopkins University, MD) and maintained in McCoy’s 5A
medium supplemented with 10% fetal bovine serum (HyClone,
Logan, UT), penicillin (100 units per ml) and streptomycin
(100 mg/ml) in a humidified incubator at 37uC (5% CO2).
Exponentially growing cells in T75 flask with 70–80% confluence
were exposed to radiation at room temperature using a Cabinet X-
rays System Faxitron Series (dose rate: 0.997 Gy/min; 130 kVp;
Hewlett Packard, McMinnville, OR). Cells sheltered from
radiation were used as the sham-IR control.
Cell transfection
Scrambled siRNA was purchased from Ambion (Austin, TX)
(4635). siRNA targeting cyclin B1 or Cdk1 mRNAs was designed
and synthesized with the Silencer siRNA Construction Kit (Ambion).
The primers used to synthesize the siRNAs were as follows:
cyclin B1, 59 AATTTCTGGAGGGTACATTTCCCTGTC-
TC 39 (Sense) and
59 AAGAAATGTACCCTCCAGAAACCTGTCTC 39 (Anti-
sense);
Cdk1, 59 AAGGGGTTCCTAGTACTGCAACCTGTCTC 39
(Sense) and
59 AATTGCAGTACTAGGAACCCCCCTGTCTC 39 (Anti-
sense).
Cells were seeded to achieve 30%–50% confluence on the day
of transfection. Transient transfection of siRNA was performed
using Lipofectamine
TM RNAiMAX reagent (Invitrogen, Carlsbad,
CA). In brief, cells were seeded in 35 mm plates and cultured in
antibiotic-free medium for 24 h, and then were transfected with
20 nM of siRNAs. Scrambled RNA Duplex (Ambion) served as
the control. All transfectants were maintained in antibiotic-free
complete medium.
Mitochondrial fractionation
Exponentially growing HCT116 p53
+/+ cells at 50–80%
confluence were used for protein fractionation. Cytosolic and
mitochondrial fractions were collected using mitochondria isola-
tion kit from Thermo Scientific (Rockford, IL) (89874). Briefly,
cells were incubated in ice-cold hypotonic buffer containing
10mM NaCl, 1.5 mM MgCl2 and 10mM Tris-HCl pH 7.5 for
20 min and cell membrane was disrupted by glass pestle and
buffer containing 2M sucrose, 35 mM EDTA and 50 mM Tris-
HCl pH 7.5 was added to prevent damages to mitochondria by
osmotic pressure. Mitochondrial fraction was then separated by
centrifugation at 12000 rpm for 20 min.
Immunoblotting and Co-immunoprecipitation
Unless noted otherwise, cytosolic fraction or total cell or
mitochondrial lysates (20 mg) were separated by SDS-PAGE and
blotted onto nitrocellulose membrane. The membrane was
incubated with specific primary antibody overnight at 4uC,
Figure 7. Schematic illustration of the nucleus-to-mitochondria signaling under DNA-damaging stress. DNA-damage irradiation
stimulates the gene expression and mitochondrial translocation of p53, cyclin B1 and Cdk1. Mitochondrial cyclin B1 and Cdk1 form a functional
complex to phosphorylate p53, which leads to enhanced ATP production and suppression of mitochondria-mediated apoptosis.
doi:10.1371/journal.pone.0012341.g007
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antibody for 1h, and visualized by the ECL Western blotting
detection system (Amersham, Arlington Heights, IL). The
antibody against p53 (sc-1019), actin (sc-8432), cyclin B1 (sc-
245), p53 (sc-126), Mfn1 (sc-166644) and Drp1 (sc-32898) were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Anti-Cox4 (ab14744) was bought from Abcam (Cambridge, MA).
The secondary antibodies were from ebioscience (San Diego, CA)
(18–8816 and 18–8817).
Mitochondrial extracts were prepared with lysis buffer contain-
ing 10 mM HEPES, 10 mM KCl, 1.5 mM MgCl2, 0.5 mM
DTT, 1% NP40, 1 mM phenylmethylsulfonyl fluoride, 25%
glycerol, and 0.2 mM EDTA. Extracts were further centrifuged at
4uC for 15 min and precleared by 1-h treatment with prebleed
sera or normal mouse or rabbit immunoglobulin G and 20 mLo f
1:1 slurry of protein A/G-Sepharose beads at 4uC. Immunopre-
cipitation preceded at least 2 h at 4uC, followed by the addition of
protein A/G beads and further 30 min incubation. Beads were
collected by brief centrifugation, washed four times with 16PBS
washing buffer, boiled in denature loading buffer, separated by
10% SDS-PAGE gel, and followed by immunoblotting as stated
above.
Plasmid Construction
pEGFP-N1 vector from Clontech (Mountain View, CA)
(Accession # U55762) was used to insert the mitochondrial
targeting sequence from Cox8a following by cyclin B1 or Cdk1
gene. In the case of RFP, EGFP is replaced by RFP at the
restriction sites indicated in the plasmid sequences.
Fluorescence microscopy analyses
HCT116 p53
+/+ cells were transfected with vectors containing
EGFP or RFP. For Mitotracker staining, 5 mM Mitotracker Red
or Green (Invitrogen) were added into cell medium for 5 min and
rinse twice with PBS then fixed in ice-cold 3.7% formaldehyde for
fluorescence microscopy.
In vivo kinase assay
Mitochondrial Cdk1-cyclin B1 complexes were purified by
immunoprecipitation from 2.4 mg of extract derived from
mitochondrial fraction of irradiated cells using 1.2 mgo fm o u s e
monoclonal anti-Cdk1 antibody and 20 ml of protein G-
Sepharose beads. After a 3-h incubation at 4uC, the beads were
washed three times with 1% Triton-X 100 buffer and two times
with kinase buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2,
1 mM EGTA, 2 mM DTT and 0.01% Brij 35. 8 mg of GST or
GST-p53 substrate was added in kinase buffer containing 1 mlo f
[c-
32P] ATP (10 mCi/ml) (Perkin Elmer) and 0.1 M cold ATP.
The reaction was incubated at 30uC for 30 min and stopped by
boiling in 56 LSB for 5 min. Purified Cdc2 (Cdk1-cyclin B
complex) kinase was purchased from New England Biolabs
(Ipswich, MA) and used according to the manufacturer’s
instructions.
Measurement of ATP production in mitochondria
To measure ATP production, ATP was extracted from
cells with 2.5% trichloroacetic acid then neutralized with Tris
pH 7.75. The ATP extracts were used to measure ATP
production using ATP determination kit (Invitrogen) according
to the manufacturer’s instructions, with luminometer (Turner
Biosystem, Sunnyvale, CA). The experiments were performed
three times individually and each experiment contained triple
replicates.
Measurement of mitochondrial membrane potential
Mitochondrial membrane potential measurement was per-
formed as previously described [66]. Briefly, mitochondrial
membrane potential was measured using a fluorescent cationic
dye, 5,59,6,69-tetrachloro-1,19,3,39-tetraethyl-benzamidazolocar-
bocyanin iodide (JC-1; Molecular Probes, Eugene, OR, USA).
The changes in membrane potential were determined by the levels
of relative fluorescence units, using a SpectraMax M5 MultiMode
Microplate Reader (Molecular Devices, Sunnyvale, CA, USA),
with a 485 nm excitation filter and a 525–595 nm emission filter.
Cell viability assay
Exponentially growing cells were plated at cell densities of
10,000 cells per well in 96-well tissue culture plates for 24 h. Cells
were then exposed to sham or 5 Gy X-rays. 24 h post-irradiation,
cell proliferation was measured by MTT assay according to the
manufacturer’s instructions (Promega, Madison, WI). Briefly,
10 ml of MTT reagent (5 mg/ml in water) was added into each
well and incubated for 2 h. Then 100 ml of 10% SDS with 0.01M
HCl was added into each well and incubated for an additional 2 h.
The plates were read with micro-plate reader at absorbance of
570 nm. The experiments were independently performed three
times and each experiment contained triple replicates.
FACS analysis
To detect apoptotic cells, exponentially growing cells were
exposed to 5 Gy of X-rays. At 24 h post-irradiation, the cells were
trypsinized and fixed with ice-cold 70% (v/v) ethanol. The cell
pellets were prepared by centrifugation at 200 g for 5 min, washed
with phosphate-buffered saline (pH 7.4), and resuspended in
phosphate buffer saline containing propidium iodide (50 mg/ml),
0.1 mg/ml bovine serum albumin, Triton X-100 (0.1%, v/v), and
DNase-free RNase (0.2 mg/ml) for 30 min at room temperature.
DNA content was determined by flow cytometry analysis using a
FACScan flow cytometer (Becton Dickinson, San Jose, CA).
Statistical analysis
The data are presented as the means 6 S.E.M. Statistical
significance among groups was determined by using paired, two-
tailed Student’s t tests with SAS software (version 9). The findings
were considered significant at P,0.05 and highly significant at
P,0.01.
Supporting Information
Figure S1 Mitochondrial interaction between p53 and Cdk1. (A)
Cdk1 and p53 were co-immunoprecipitated from mitochondrial
fractions of HCT116 p53+/+ exposed to sham or 5 Gy X-rays at
2 and 4 h post-irradiation. Whole cell lysate of HCT116 p532/2
was used as the negative control. (B) Synthesis and purification of
GST-tagged p53 proteins. GST-tagged p53 wild-type and mutants
(S315A and S315D) were synthesized in BL-21 E.Coli and purified
by immobilized gluthathione beads (Thermo Scientific).
Found at: doi:10.1371/journal.pone.0012341.s001 (0.28 MB TIF)
Figure S2 Mitochondrial cyclin B1/Cdk1 phosphorylated Ser-
315 residue of p53. (A) Phosphorylated p53 at Ser-315 was
detected by immunoblotting from whole cell lysate of HCT116
cells exposed to 10 Gy X-rays at indicated time. Phosphorylation
of p53 at Ser-315 was enhanced by ionizing radiation. (B)
Fluorescence immunostaining of 5 Gy irradiated mouse xenograft
tissue generated from human glioblastoma cell line U87 showing
mitochondria localization of phosphorylated p53 (Ser-315) and
Cdk1. Tissue were collected 24 h after irradiation. Cox4 staining
p53 Anti-Apoptotic Function
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Expression of cyclin B1 and Cdk1 were detected by immunoblot-
ting in whole cell lysates of HCT116 cells transfected with cyclin
B1, Cdk1 and scrambled siRNA at the concentration of 20 nM,
cells transfected with Lipofectamine only were included as control.
(D) Mitochondrial cyclin B1, cyclin B1-EGFP, Cdk1 and Cdk1-
RFP were detected by immunoblotting in HCT116 cells
transfected with mitochondria-targeted EGFP and RFP (MTS-
EGFP/RFP; served as vector control), mitochondria-targeted
cyclin B1-EGFP and Cdk1-RFP (MTS-cyclin B1/MTS-Cdk1),
and mitochondria-targeted cyclin B1-EGFP and Cdk1 with
deletion in its catalytic loop (residue 122–132) linked with RFP
(MTS-cyclin B1/MTS-delCdk1) along with mitochondrial frac-
tion of HCT116 cells without any transfection. (E) Representative
images of HCT116 p53+/+ cells transfected with MTS-EGFP and
MTS-RFP with Mitotracker for mitochondrial staining (scale
bar=5 mm).
Found at: doi:10.1371/journal.pone.0012341.s002 (2.95 MB TIF)
Figure S3 Effect of p53 in mitochondrial ATP production. (A)
HCT116 p532/2 cells were transfected with p53 (wild-type) and
mutants (S315A and S315D) linked with myc-tag in plasmid
containing Zeocin resistance gene and the transfectants were
selected with Zeocin (150 mg/ml) for 6 days. Expression of p53 in
the stable transfectants were detected by western blot comparing
to p53 expression in HCT116 p53+/+ and HCT116 p532/2. (B)
ATP production was measured in HCT116 p53+/+ and HCT116
p532/2 cells exposed to sham or 5 Gy X-rays at indicated time
points after irradiation. Displayed is the mean 6SEM; n=3;
**P,0.01. The enhanced ATP production is likely due to the
influx of cyclin B1, Cdk1 and p53 to mitochondria.
Found at: doi:10.1371/journal.pone.0012341.s003 (0.37 MB TIF)
Figure S4 Limited effect on mitochondrial fission by ionizing
radiation and mitochondrial cyclin B1, Cdk1 and p53. Expression
of Drp1 and Mfn1 was detected by immunoblotting from 5 Gy
irradiated whole cell and mitochondrial fraction of HCT116
p53+/+ cells at indicated time points post-irradiation. b-actin and
Cox4 served as the loading controls.
Found at: doi:10.1371/journal.pone.0012341.s004 (0.31 MB TIF)
Figure S5 Pro-survival effects of cyclin B1/Cdk1-mediated p53
phosphorylation. (A) Clonogenic survival of HCT116 p53+/+,
HCT116 p532/2, HCT116 p532/2 +p53WT, HCT116
p532/2 +p53S315A and HCT116 p532/2 +p53S315D cells
exposed to 5 Gy X-rays, colonies were stained and counted 10
days post-irradiation (n=3, mean 6 SEM; **P,0.01). (B)
Apoptotic cell measurement by flow cytometry after 5 Gy
irradiation. Cell were collected at 24 h after irradiation, fixed
and stained by propidium iodine for apoptotic cell counts (n=3,
mean 6 SEM). (B) The same set of cell lines were transfected with
scrambled, cyclin B1 or Cdk1 siRNA for 24 h and irradiated with
5 Gy X-rays. Cells were collected at 24 h post-irradiation and
analyzed by flow cytometry with propidium iodine staining (n=3,
mean 6 SEM; *P,0.05; **P,0.01).
Found at: doi:10.1371/journal.pone.0012341.s005 (0.62 MB TIF)
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